Keane's Corner VL

ASCO 2017: Discussion of LATITUDE and STAMPEDE Trials

Discussion about LATITUDE and STAMPEDE trials from the 2017 ASCO annual meeting in Chicago, Illinois - June 2 - 6, 2017 Biography: Thomas E. Keane Related Content: Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy LATITUDE abstract from ASCO 2017 STAMPEDE abstract from ASCO 2017 STAMPEDE - Cli...

Active Surveillance: Protecting Patients From Harm- Laurence Klotz

Protecting Patients From Harm - Active Surveillance Biographies: Thomas E Keane Laurence Klotz, MD Related Content: Active Surveillance in PCa+ Active surveillance in prostate cancer: a critical review

Tom Keane Highlights Notable SUO 2016 Presentations

Tom Keane, MD reviews three state of the art presentations from Society of Urologic Oncology Meeting (SUO) December 2016. First Dr. Keane desribes a state of the art lecture given by Martin Gleeve, MD. Read the report from the session here - State of the Art lecture: Genomic profiling and clinical implications of atypical intermediate prostate cancer phenotype - Dr. Keane then provides an overview...

SIU 2016: 36th Congress Highlights

This editon of Keane's Corner reviews the top sessions from the SIU 2016 including prostate cancer and urothelial cancer. Visit UroToday's SIU Conference Highlights Section for additional content Biography: Thomas E. Keane, MBBCh, FRCSI, FACS, is Professor and Chairman of the Department of Urology at the Medical University of South Carolina in Charleston. Dr. Keane specializes in managing prostate...

Journal Club: Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormones Agonist and an Antagonist

Thomas Keane provides a journal club review on the article, "Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormones Agonist and an Antagonist", published in the European Association of Urology. The hypothesis and approach for this article includes a discussion around if a GnRH antagonist produce the same risk of cardiovascular complication when compared to an LHRH agonist. Also,...

Role of the Gonadotrophin-Releasing Hormone Antagonists and Advanced Hormone-Dependent Prostate Cancer - Journal review

This edition of Keane’s Corner is a Journal Club discussion on the article, “The Role of the Gonadotrophin-Releasing Hormone Antagonists in the Treatment of Patients with Advanced Hormone-Dependent Prostate Cancer in the UK”, published in the World Journal of Urology. Authors: Derek J. Rosario, Patrick Davey, James Green, Damien Greene, Bruce Turner, Heather Payne and Mike Kirby An overview of the...

Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer

A journal club article review presented by Thomas Keane, MD. “Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients with Prostate Cancer”. Written by: Nirmanmoh Bhatia, Marilia Santos, Lee W. Jones, Joshua A. Beckman, David F. Penson, Alicia K. Morgans and Javid Moslehi In this presentation of the journ...

ASCO 2016: Keane's Corner blog - Bladder Cancer.

Thomas Keane, Editor-in-Chief, discusses new treatment advances for patients with metastatic urothelial cancer. The standard of care for patients with locally advanced or metastatic urothelial cancer is currently cisplatin-based chemotherapy, which is the only therapy ever shown to improve survival in this setting. However, nearly half of patients diagnosed with this disease will not...

AUA 2016 Roundup: Prostate Cancer

Thomas Keane discusses key highlights from the AUA 2016

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.